23.8 C
New York
Wednesday, June 10, 2026

Tag: petition

CLINICIANS AT THREE OF WASHINGTON’S LARGEST HEALTHCARE SYSTEMS FILE TO UNIONIZE, CITING PATIENT CARE CONCERNS

SEATTLE, June 9, 2026 /PRNewswire/ -- Two hundred and fifty nurse practitioners and physician assistants working across multiple clinic locations at Fred Hutchinson Cancer...

TEAMSTERS-LED FASTER LABOR CONTRACTS ACT PASSES U.S. HOUSE WITH BIPARTISAN SUPPORT

Landmark Labor Law to Ensure Fair First Contracts for Workers Heads to U.S. SenateWASHINGTON, June 9, 2026 /PRNewswire/ -- With bipartisan support, the U.S....

Legal Win for Tsetsaut Skii km Lax Ha Nation: B.C. Supreme Court Strikes Down Substantial Start Determination for KSM Mine and Orders Proper Consultation;...

HAZELTON, BC, June 9, 2026 /CNW/ - Yesterday, the B.C. Supreme Court issued its decision on the Tsetsaut Skii km Lax Ha (TSKLH) Nation's...

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the...

NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

FLYWIRE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff...

NEW YORK CITY and NEW ORLEANS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against Flywire Corporation (“Flywire” or the “Company”) (NasdaqGS: FLYW), if they purchased the Company’s securities between February 28, 2024 and February 25, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000...

NEW YORK and NEW ORLEANS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’s securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Northern District of California.

Bragar Eagel & Squire, P.C. Reminds Investors of Flywire, Lockheed Martin, and Sable Offshore that Lawsuits Have Been Filed and Encourages Investors to Contact...

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Flywire Corporation (NASDAQ:FLYW), Lockheed Martin Corporation (NYSE:LMT), and Sable Offshore Corporation (NYSE:SOC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

State regulators grant time for FPL and key stakeholders to finalize settlement that keeps customer bills well below national average

JUNO BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- State regulators unanimously agreed today to give Florida Power & Light Company and key stakeholder groups...

FPL reaches agreement in principle with key stakeholders that would keep customer bills well below national average

JUNO BEACH, Fla., Aug. 8, 2025 /PRNewswire/ -- Florida Power & Light Company and key stakeholder groups have reached an agreement in principle on...

Ammunition Depot Issues Update on California Ammunition Sales – Ninth Circuit Victory on Hold as State Seeks En Banc Review

Ninth Circuit Victory on Hold as California Seeks En Banc Rehearing BOCA RATON, Fla., Aug. 8, 2025 /PRNewswire/ -- In a major Second Amendment ruling,...

SABLE OFFSHORE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead...

NEW YORK and NEW ORLEANS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 26, 2025 to file lead plaintiff applications in a securities class action lawsuit against Sable Offshore Corp. (NYSE: SOC), if they purchased the Company’s securities (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to Sable’s May 21, 2025 secondary public offering (the “SPO”). This action is pending in the United States District Court for the Central District of California.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPetition